Routine newborn screening (NBS) has transformed early disease detection. However, traditional biochemical tests limit the ...
In drug development projects, evaluating drug-target residence times can enhance drug efficacy, widen the therapeutic window, and reduce the likelihood of prematurely advancing candidate compounds ...
Biochemistry is the study of the chemicals and chemistry of living organisms. Biochemists study biomolecules (such as proteins, RNA, DNA, sugars, and lipids), their applications and interactions in ...
Targeted protein degradation (TPD) is a promising alternative to conventional small-molecule drugs. Rather than inhibiting a single enzyme’s function, degrader molecules label selected ...
Time-resolved fluorescence resonance energy transfer (TR-FRET) combines fluorescence detection with temporal resolution to significantly enhance assay performance. This technology minimizes background ...
Dr. Markus Gershater explains how High Dimensional Experimentation (HDE) revolutionizes assay development by replacing ...
Gregory Russotti is the Chief Technology and Manufacturing Officer at Century Therapeutics, a company developing iPSC-derived, allogeneic immune cell therapy products for hematology/oncology ...
My overall goal is to mentor a vibrant research team focused on developing new ultrafast vibrational spectroscopy techniques for investigating biological systems on the sub-micron scale. We will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results